For research use only. Not for therapeutic Use.
Ixekizumab（Cat No.:I044216）is a humanized IgG4 monoclonal antibody that specifically targets interleukin-17A (IL-17A), a pro-inflammatory cytokine involved in the pathogenesis of several autoimmune diseases. By neutralizing IL-17A, ixekizumab reduces inflammation and inhibits the abnormal immune response seen in conditions like plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis. Administered via subcutaneous injection, it provides rapid and sustained improvement in skin and joint symptoms. Ixekizumab is known for its high efficacy in achieving skin clearance and improving quality of life, offering a targeted therapeutic option for chronic inflammatory disorders.
| CAS Number | 1143503-69-8 |
| Purity | ≥95% |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
